#SanstecSnippets
Johnson & Johnson consolidates medtech brands under single
banner - Going forward, the conglomerate’s Ethicon, DePuy Synthes,
Biosense Webster, Abiomed and Cerenovus marques will all operate under the
name Johnson & Johnson MedTech.
https://www.fiercebiotech.com/medtech/johnson-johnson-consolidates-medtech-brands-under-single-banner
Schneider Electric to invest £42m in new manufacturing site in
North Yorkshire - Schneider Electric is investing £42m in a new
manufacturing facility in Scarborough, North Yorkshire. More than 200 jobs
will be created to meet the increased demand for electrical equipment to
drive the UK’s move to cleaner energy including renewable energy sources,
electric vehicles, and intelligent, energy-efficient buildings.
https://www.themanufacturer.com/articles/schneider-electric-to-invest-42m-in-new-manufacturing-site-in-north-yorkshire
Molex to acquire Vectura Group Limited, expanding drug delivery
capabilities in inhalation - Pharmaceutical customers and patients
to benefit from the combined design, development and manufacturing services
of Vectura and Phillips Medisize.
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/drug-delivery-news/molex-to-acquire-vectura-group-limited-expanding-drug-delivery-capabilities-in-inhalation/
UK Manufacturing slips to 12th in rankings - Britain’s
manufacturing sector has dropped out of the top 10 for the first time.
https://teng.mydigitalpublication.co.uk/publication page 10.
UK unveils plans to plug up to $527M into clinical trials,
manufacturing and more - Amid a years long clinical trial decline
in the U.K., a new public-private partnership named The Voluntary Scheme for
Branded Medicine Pricing, Access and Growth (VPAG) investment program, has
emerged in efforts to reinvigorate the country’s pharmaceutical testing
prowess.
https://www.fiercebiotech.com/biotech/uk-unveils-new-investment-program-plans-plug-ps400m-clinical-trials-manufacturing-and-more
